Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: Relevance to human metabolic syndrome

Clinical Science

Volumn 127, Issue 7, 2014, Pages 449-461

  Ceolotto, Giulio ^a   de Kreutzenberg, Saula Vigili ^a   Cattelan, Arianna ^a   Fabricio, Aline S C ^b   Squarcina, Elisa ^b   Gion, Massimo ^b   Semplicini, Andrea ^a   Fadini, Gian Paolo ^a   Avogaro, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b ULSS 12   (Italy)

Author keywords

Cell adhesion; Diabetes; Endothelial dysfunction; Inflammation; Metabolic syndrome; Transcription factor

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; HUR PROTEIN; RESVERATROL; RIBONUCLEOPROTEIN; SIRTINOL; SIRTUIN 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ACETYLATION; ADULT; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DEACETYLATION; EX VIVO STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOPRECIPITATION; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STABILITY; UMBILICAL VEIN ENDOTHELIAL CELL;

ACETYLATION; ADHESIVENESS; BENZAMIDES; CELL ADHESION; E-SELECTIN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GLUCOSE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; LEUKOCYTES, MONONUCLEAR; METABOLIC SYNDROME X; NAPHTHOLS; NF-KAPPA B; PROTEIN STABILITY; SIRTUIN 1; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903973661     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130439     Document Type: Article

References (54)

1. Ford, E. S. (2005) Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28, 1769-1778 CrossRef PubMed
2. Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P. and Garg, R. (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448-1454 CrossRef PubMed
3. Davies, M. J., Gordon, J. L., Gearing, A. J., Pigott, R., Woolf, N., Katz, D. and Kyriakopoulos, A. (1993) The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol. 171, 223-229 CrossRef PubMed
4. Hwang, S. J., Ballantyne, C. M., Sharrett, A. R., Smith, L. C., Davis, C. E., Gotto, A. M. and Boerwinkle, E. (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96, 4219-4225 CrossRef PubMed
5. Lopes-Virella, M. F., Carter, R. E., Gilbert, G. E., Klein, R. L., Jaffa, M., Jenkins, A. J., Lyons, T. J., Garvey, W. T. and Virella, G. (2008) Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care 31, 2006-2012 CrossRef PubMed
6. Natarajan, A., Marshall, S. M., Kesteven, P. J., McComb, J. M. and Rutter, M. K. (2011) Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in type 2 diabetes. Diabet. Med. 28, 1201-1205 CrossRef PubMed
7. Richardson, M., Hadcock, S. J., DeReske, M. and Cybulsky, M. I. (1994) Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler. Thromb. Vasc. Biol. 14, 760-769 CrossRef
8. Matsumoto, K., Miyake, S., Yano, M., Ueki, Y. and Tominaga, Y. (2000) High serum concentrations of soluble E-selectin in patients with impaired glucose tolerance with hyperinsulinemia. Atherosclerosis 152, 415-420 CrossRef PubMed
9. Matsumoto, K., Sera, Y., Abe, Y., Tominaga, T., Horikami, K., Hirao, K., Ueki, Y. and Miyake, S. (2002) High serum concentrations of soluble E-selectin correlate with obesity but not fat distribution in patients with type 2 diabetes mellitus. Metabolism 51, 932-934 CrossRef PubMed
10. Cominacini, L., Fratta Pasini, A., Garbin, U., Davoli, A., De Santis, A., Campagnola, M., Rigoni, A., Zenti, M. G., Moghetti, P. and Lo Cascio, V. (1995) Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38, 1122-1124 CrossRef PubMed
11. Albertini, J. P., Valensi, P., Lormeau, B., Aurousseau, M. H., Ferriere, F., Attali, J. R. and Gattegno, L. (1998) Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care 21, 1008-1013
12. Kado, S. and Nagata, N. (1999) Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 46, 143-148 CrossRef PubMed
13. Elhadd, T. A., Kennedy, G., McLaren, M., Stonebridge, P. A., Shaw, W. J. and Belch, J. J. (2000) Elevated levels of soluble E-selectin in diabetic patients with severe symptomatic peripheral arterial occlusive disease requiring angioplasty. A possible role in diabetic vascular disease? Int. Angiol. 19, 171-175 PubMed
14. Trøseid, M., Lappeg̊ard, K. T., Mollnes, T. E., Arnesen, H. and Seljeflot, I. (2005) Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome. Scand. J. Clin. Lab. Invest. 65, 283-290 CrossRef PubMed
15. Narumi, S., Onozato, M. L., Tojo, A., Sakamoto, S. and Tamatani, T. (2001) Tissue-specific induction of E-selectin in glomeruli is augmented following diabetes mellitus. Nephron 89, 161-171 CrossRef PubMed
16. Soedamah-Muthu, S. S., Chaturvedi, N., Schalkwijk, C. G., Stehouwer, C. D., Ebeling, P. and Fuller, J. H. (2006) Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in type 1 diabetic patients. J. Diabetes Complications 20, 188-195 CrossRef PubMed
17. Ersanli, D., Top, C., Oncül, O., Aydin, A. and Terekeci, H. (2007) Relationship between serum soluble E-selectin levels and development of diabetic retinopathy in patients with type 2 diabetes. Scand. J. Clin. Lab. Invest. 67, 474-479 CrossRef PubMed
18. Boyle, E. M., Kovacich, J. C., Canty, Jr, T. G., Morgan, E. N., Chi, E., Verrier, E. D. and Pohlman, T. H. (1998) Inhibition of nuclear factor-kappa B nuclear localization reduces human E-selectin expression and the systemic inflammatory response. Circulation. 98, II282-II288 PubMed
19. Chen, C. C., Rosenbloom, C. L., Anderson, D. C. and Manning, A. M. (1995) Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J. Immunol. 155, 3538-3545 PubMed
20. Yu, G., Rux, A. H., Ma, P., Bdeir, K. and Sachais, B. S. (2005) Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. Blood 105, 3545-3551 CrossRef PubMed
21. Glass, C. K. and Olefsky, J. M. (2012) Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 15, 635-645 CrossRef PubMed
22. Deisher, T. A., Sato, T. T., Pohlman, T. H. and Harlan, J. M. (1993) A protein kinase C agonist, selective for the beta I isozyme, induces E-selectin and VCAM-1 expression on HUVEC but does not translocate PKC. Biochem. Biophys. Res. Commun. 193, 1283-1290 CrossRef PubMed
23. Rupin, A., Paysant, J., Sansilvestri-Morel, P., Lembrez, N., Lacoste, J. M., Cordi, A. and Verbeuren, T. J. (2004) Role of NADPH oxidase-mediated superoxide production in the regulation of E-selectin expression by endothelial cells subjected to anoxia/reoxygenation. Cardiovasc. Res. 63, 323-330 CrossRef PubMed
24. Higai, K., Shimamura, A. and Matsumoto, K. (2006) Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation. Clin. Chim. Acta 367, 137-143 CrossRef PubMed
25. Ceolotto, G., Bevilacqua, M., Papparella, I., Baritono, E., Franco, L., Corvaja, C., Mazzoni, M., Semplicini, A. and Avogaro, A. (2004) Insulin generates free radicals by an NAD(P)H, phosphatidylinositol 3'-kinase-dependent mechanism in human skin fibroblasts ex vivo. Diabetes 53, 1344-1351 CrossRef PubMed
26. Ceolotto, G., Gallo, A., Papparella, I., Franco, L., Murphy, E., Iori, E., Pagnin, E., Fadini, G. P., Albiero, M., Semplicini, A. and Avogaro, A. (2007) Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler. Thromb. Vasc. Biol. 27, 2627-2633 CrossRef
27. Piconi, L., Quagliaro, L., Da Ros, R., Assaloni, R., Giugliano, D., Esposito, K., Szabó, C. and Ceriello, A. (2004) Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J. Thromb. Haemost. 2, 1453-1459 CrossRef PubMed
28. Quagliaro, L., Piconi, L., Assaloni, R., Da Ros, R., Maier, A., Zuodar, G. and Ceriello, A. (2005) Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183, 259-267 CrossRef PubMed
29. Richter, V., Rassoul, F., Purschwitz, K., Hentschel, B., Reuter, W. and Kuntze, T. (2003) Circulating vascular cell adhesion molecules VCAM-1, ICAM-1, and E-selectin in dependence on aging. Gerontology 49, 293-300 CrossRef PubMed
30. Vannini, N., Pfeffer, U., Lorusso, G., Noonan, D. M. and Albini, A. (2008) Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model. Curr. Pharm. Des. 14, 221-225 CrossRef PubMed
31. Gillum, M. P., Kotas, M. E., Erion, D. M., Kursawe, R., Chatterjee, P., Nead, K. T., Muise, E. S., Hsiao, J. J., Frederick, D. W., Yonemitsu, S. et al. (2011) SirT1 regulates adipose tissue inflammation. Diabetes 60, 3235-3245 CrossRef PubMed
32. Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B. et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716 CrossRef
33. de Kreutzenberg, S. V., Ceolotto, G., Papparella, I., Bortoluzzi, A., Semplicini, A., Dalla Man, C., Cobelli, C., Fadini, G. P. and Avogaro, A. (2010) Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59, 1006-1015 CrossRef PubMed
34. Yoshizaki, T., Schenk, S., Imamura, T., Babendure, J. L., Sonoda, N., Bae, E. J., Oh, D. Y., Lu, M., Milne, J. C., Westphal, C. et al. (2010) SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 29, E419-E428 CrossRef
35. Kim, H. H., Yang, X., Kuwano, Y. and Gorospe, M. (2008) Modification at HuR (S242) alters HuR localization and proliferative influence. Cell Cycle 7, 3371-3377 CrossRef PubMed
36. Read, M. A., Whitley, M. Z., Gupta, S., Pierce, J. W., Best, J., Davis, R. J. and Collins, T. (1997) Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 272, 2753-2761 CrossRef PubMed
37. Kwon, H. S. and Ott, M. (2008) The ups and downs of SIRT1. Trends Biochem. Sci. 33, 517-525 CrossRef PubMed
38. Doller, A., Pfeilschifter, J. and Eberhardt, W. (2008) Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. Cell. Signal. 20, 2165-2173 CrossRef PubMed
39. Rhee, W. J., Ni, C. W., Zheng, Z., Chang, K., Jo, H. and Bao, G. (2010) HuR regulates the expression of stress-sensitive genes and mediates inflammatory response in human umbilical vein endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 107, 6858-6863 CrossRef PubMed
40. Abdelmohsen, K., Pullmann, R., Lal, A., Kim, H. H., Galban, S., Yang, X., Blethrow, J. D., Walker, M., Shubert, J., Gillespie, D. A. et al. (2007) Phosphorylation of HuR by ChK2 regulates SIRT1 expression. Mol. Cell 25, 543-557 CrossRef PubMed
41. Edelstein, L. C., Pan, A. and Collins, T. (2005) Chromatin modification and the endothelial-specific activation of the E-selectin gene. J. Biol. Chem. 280, 11192-11202 CrossRef PubMed
42. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A. and Mayo, M. W. (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380 CrossRef PubMed
43. Yang, J., Wang, N., Li, J., Zhang, J. and Feng, P. (2010) Effects of resveratrol on NO secretion stimulated by insulin and its dependence on SIRT1 in high glucose cultured endothelial cells. Endocrine. 37, 365-372 CrossRef PubMed
44. Yang, J., Wang, N., Zhu, Y. and Feng, P. (2011) Roles of SIRT1 in high glucose-induced endothelial impairment: association with diabetic atherosclerosis. Arch. Med. Res. 42, 354-360 CrossRef PubMed
45. Kao, C. L., Chen, L. K., Chang, Y. L., Yung, M. C., Hsu, C. C., Chen, Y. C., Lo, W. L., Chen, S. J., Ku, H. H. and Hwang, S. J. (2010) Resveratrol protects human endothelium from H2O2-induced oxidative stress and senescence via SirT1 activation. J. Atheroscler. Thromb. 17, 970-979 CrossRef PubMed
46. Csiszar, A., Labinskyy, N., Podlutsky, A., Kaminski, P. M., Wolin, M. S., Zhang, C., Mukhopadhyay, P., Pacher, P., Hu, F., de Cabo, R. et al. (2008) Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am. J. Physiol. Heart Circ. Physiol. 294, H2721-H2735 CrossRef PubMed
47. Zhang, H., Zhang, J., Ungvari, Z. and Zhang, C. (2009) Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 29, 1164-1171 CrossRef PubMed
48. Stein, S. and Matter, C. M. (2011) Protective roles of SIRT1 in atherosclerosis. Cell Cycle 10, 640-647 CrossRef PubMed
49. Zhang, Q. J., Wang, Z., Chen, H. Z., Zhou, S., Zheng, W., Liu, G., Wei, Y. S., Cai, H., Liu, D. P. and Liang, C. C. (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc. Res. 80, 191-199 CrossRef PubMed
50. Brennan, C. M. and Steitz, J. A. (2001) HuR and mRNA stability. Cell. Mol. Life Sci. 58, 266-277 CrossRef PubMed
51. Iori, E., Pagnin, E., Gallo, A., Calo, L., Murphy, E., Ostuni, F., Fadini, G. P. and Avogaro, A. (2008) Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells. Life Sci. 82, 383-892 CrossRef PubMed
52. Pullmann, Jr, R., Juhaszova, M., López de Silanes, I., Kawai, T., Mazan-Mamczarz, K., Halushka, M. K. and Gorospe, M. (2005) Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR. J. Biol. Chem. 280, 22819-22826 CrossRef PubMed
53. Cuneo, A. A., Herrick, D. and Autieri, M. V. (2010) Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability. J. Mol. Cell. Cardiol. 49, 647-654 CrossRef PubMed
54. Katsanou, V., Papadaki, O., Milatos, S., Blackshear, P. J., Anderson, P., Kollias, G. and Kontoyiannis, D. L. (2005) HuR as a negative posttranscriptional modulator in inflammation. Mol. Cell 19, 777-789 CrossRef PubMed